Theravance Inc news

   Watch this stock
Showing stories 1 - 10 of about 86   

Articles published

THRX 21.78 -0.98 (-4.31%)
price chart
Theravance, Inc. Appoints Michael W. Aguiar as President and Chief Executive ...
Mr. Aguiar will replace Rick E Winningham who has resigned as Chief Executive Officer of Theravance effective August 15, 2014. Mr. Winningham will remain Chairman of the Board of Directors of Theravance, Inc. and will transition to full time Chief ...
Theravance Inc (THRX) Plans Quarterly Dividend of $0.25  WKRB News
Related articles »  
Buy Theravance After Pullback
Since announcing its split into two entities, shareholders are having a tough time holding Theravance (NASDAQ:THRX). Conversely, its spinoff company, Theravance Biopharma (NASDAQ:TBPH), is up. Hurt by an increase in bearish bets and a lack of interest ...
Theravance to Report Second Quarter 2014 Financial Results on August 6, 2014  MarketWatch
Related articles »  
BofA/Merrill Lynch Downgrades Theravance Inc. (THRX) to Neutral
BofA/Merrill Lynch downgraded Theravance Inc. (NASDAQ: THRX) from Buy to Neutral with a price target of $31.00 (from $34.00) as pricing headwinds continue.
Theravance Biopharma, Inc. Reports Second Quarter 2014 Financial Results
SOUTH SAN FRANCISCO, CA--(Marketwired - Aug 13, 2014) - Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported financial results for the second quarter 2014, and provided a corporate update.
Related articles »  
Momentum Stocks : CEMEX, S.A.B. de C.V. (NYSE:CX), Theravance Inc ...
On JULY 18, CEMEX, S.A.B. de C.V. (NYSE:CX), announced that consolidated net sales reached U.S.$4.2 billion during the second quarter of 2014, an increase of 4% versus the comparable period in 2013.
Top News : Halcon Resources Corp. (NYSE:HK), Theravance Inc. (NASDAQ ...
Theravance Inc. (NASDAQ:THRX) second quarter 2014 loss of 18 cents per share was narrower than the Zacks Consensus Estimate of a loss of 53 cents.
Investors Alert: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Theravance Inc ...
Lakeway, NY - (MARKET NEWS CALL) - 7/28/2014�, an investment community with a special focus on updating investors with recent news on the U.S.
Investor's Watch List - Terex Corporation (NYSE:TEX), Theravance Inc(NASDAQ ...
Theravance Inc(NASDAQ:THRX) recently declared the start of a global phase III study, known as IMPACT, to evaluate the efficacy and safety of the 'closed' triple combination of FF/UMEC/VI in patients with chronic obstructive pulmonary disease (COPD).
Theravance Lowered to "Neutral" at Bank of America (THRX)  Watch List News (press release)
Theravance Lowered to �Neutral� at Morgan Stanley (THRX)  Ticker Report
Related articles »  
Active Watch List : Tesla Motors (NASDAQ:TSLA), Theravance Inc. (NASDAQ ...
Tesla Motors Inc (TSLA), the electric-car maker led by Elon Musk, said it resolved a trademark dispute in China that threatened to complicate the company's plans to increase sales in the world's largest auto market.
Market Updates on Pharma Stocks -- Theravance, Akorn, Endo Intl., Pernix ...
Investor-Edge has initiated coverage on the following equities: Theravance Inc. THRX, +0.00% Akorn Inc. AKRX, +0.67% Endo International PLC ENDP, -1.47% Pernix Therapeutics Holdings Inc. PTX, +0.42% and Depomed Inc. DEPO, +2.99% Free research ...
Related articles »